Dr. Kumar Srinivasan

Dr. Kumar Srinivasan

Kumar Srinivasan, Ph.D., MBA, in his most recent role served as executive vice president and chief business officer at Turning Point Therapeutics with responsibility for corporate strategy and business development,
Dr. Shubhada Chiplunkar

Dr. Shubhada Chiplunkar

Prof Shubhada Chiplunkar Former Director of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai and the Head of Cancer Immunology and Immunotherapy
Hariharnath Buggana

Hariharnath Buggana

Hariharnath Buggana is the Managing Director of InvAscent India – a private equity firm focused on Indian healthcare, pharma, and medtech industries. Prior to this, Hari was a consultant with
Dr. Bruce Carter

Dr. Bruce Carter

Dr. Bruce LA Carter is an independent member of the board at Dr. Reddy’s for the past seven years. He started his long and illustrious career in the biopharma industry
Patrick Aghanian

Patrick Aghanian

Patrick Aghanian is the Chief Executive Officer for European Generics at Dr. Reddy’s Laboratories Limited and a member of Dr. Reddy’s Management Council. Patrick joined Dr. Reddy’s from Zentiva in
Parag Agarwal

Parag Agarwal

Parag Agarwal is the Chief Financial Officer of Dr. Reddy’s Laboratories Limited. He joined Dr. Reddy’s from London-based Reckitt Benckiser PLC, where he was the CFO for Health. In a
Satish Reddy

Satish Reddy

Satish Reddy is the Chairman of Dr. Reddy’s Laboratories. He joined the company in 1993 and since then, has held positions of increasing responsibility. Satish led the organization’s transition from
G V Prasad

G V Prasad

G V Prasad is the Co-chairman and Managing Director of Dr. Reddy’s Laboratories Ltd. He is widely credited as the architect of Dr. Reddy’s successful global generics strategy. He envisioned